Page 13 - Hikma - Oncology booklet
P. 13
Indication
Cervical Cancer
Bladder cancer
Click to edit Master title style 05
01
Sarcoma Ovarian Carcinoma
ADVANCED 02 Esophageal Cancers Thymoma 06 ADVANCED
Endometrial Cancer Testicular cancer
Thymic carcinoma
Head and Neck Cancer
07
03
Melanoma
Metastatic Breast
Non-Small Cell & Retinoblastoma
04 08
Small cell lung cancer Cancer Neuroendocrine
Refractory Non-
09 Carcinoma of the Skin 10
Hodgkin's lymphoma
Pleural mesothelioma malignant
11
Refractory Hodgkin Lymphoma
Dosage
Single-Agent Therapy
360
mg/m 2 IV on day 1 every 4 weeks
Should not be repeated until the neutrophil count is at
least 2,000 and the platelet count is at least 100,000.
18/01/2020 1
12
